Shortage reports
Actual shortage:
58 (4%)
Anticipated shortage:
2 (0%)
Avoided shortage:
37 (3%)
Resolved:
1273 (93%)
1370
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
287 (99%)
Reversed:
2 (1%)
291
211 (13%)
10 (16%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2023-08-10 | 2023-09-18 | 201545 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2017-09-19 | 2018-04-19 | 22744 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-05 | 2020-10-26 | 88585 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2018-05-04 | 2018-08-24 | 48514 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2024-03-15 | 2024-07-10 | 222369 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2023-04-14 | 2023-08-17 | 189598 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2018-11-28 | 2019-02-08 | 67863 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2017-10-12 | 2018-04-19 | 25743 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-04-20 | 2018-07-13 | 46689 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98799 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2019-11-15 | 2020-05-19 | 98802 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2018-08-24 | 2019-02-08 | 59107 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-02-12 | 2018-03-07 | 39510 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-10-03 | 2019-02-08 | 63054 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98796 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-10-03 | 2019-02-08 | 63047 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2019-03-04 | 2019-06-11 | 77450 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-03-29 | 2019-06-11 | 79847 |
| PMS-CANDESARTAN HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2017-07-25 | 2018-01-26 | 17024 |
| PMS-CANDESARTAN HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2018-04-20 | 2019-02-26 | 46692 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-SODIUM CROMOGLYCATE | 1% | SOLUTION | Discontinued | 2022-07-18 | 2023-04-12 | 164809 |
| PMS-SOLIFENACIN | 5MG | TABLET | Reversed | 2020-06-15 | 2020-10-06 | 117915 |
| PMS-SOLIFENACIN | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117918 |
| PMS-SOTALOL - 160 MG | 160MG | TABLET | Reversed | 2024-08-05 | 2024-08-23 | 234583 |
| PMS-SULFASALAZINE-E.C. TAB 500MG | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2021-03-01 | 2021-03-01 | 134853 |
| PMS-SUMATRIPTAN | 50MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149391 |
| PMS-TESTOSTERONE | 40MG | CAPSULE | Discontinued | 2025-05-13 | 2025-05-13 | 257211 |
| PMS-TESTOSTERONE | 40MG | CAPSULE | Discontinued | 2025-05-13 | 2025-05-13 | 257208 |
| PMS-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6081 |
| PMS-TRAMADOL-ACET | 37.5MG 325MG | TABLET | Discontinued | 2018-09-19 | 2018-09-20 | 61903 |
| PMS-VALPROIC ACID | 250MG | CAPSULE | Discontinued | 2017-10-27 | 2017-10-27 | 27377 |
| PMS-VALPROIC ACID E.C. | 500MG | CAPSULE (ENTERIC-COATED) | Discontinued | 2020-06-15 | 2021-10-27 | 117757 |
| PMS-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-07-25 | 2022-07-25 | 165500 |
| PMS-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-07-25 | 2022-07-25 | 165495 |
| PMS-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-07-25 | 2022-07-25 | 165490 |
| PMS-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-07-25 | 2022-07-25 | 165485 |
| PMS-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-07-25 | 2022-07-25 | 165480 |
| PMS-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-07-25 | 2022-07-25 | 165475 |
| PMS-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-06-15 | 2021-10-27 | 117766 |
| PMS-ZOLEDRONIC ACID | 4MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6094 |